Navigation Links
China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results
Date:5/2/2008

-- Quarterly Revenues Increase 62% to $11.7 million -- Quarterly Net Income Increases 76.5% to $4.2 million with EPS of $0.11

NEW YORK and HAIKOU, Hainan, China, May 2 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced its financial results for the first quarter of 2008.

First Quarter 2008 Highlights

-- Revenue increased 62%, to $11.7 million versus Q1 2007.

-- Net income was $4.2 million, up 76.5% versus Q1 2007.

-- Our existing products continue to generate strong sales during the

first quarter of 2008. Sales of Pusen OK have increased by $1 million,

Buflomedil Hydrochloride increased 198%, Gastrodin increased 70%, and

Cefaclor has increased 64% versus Q1 2007.

-- EPS was $0.11, up 57.1% versus Q1 2007.

Revenues for the first quarter of 2008 increased approximately 62% to $11.7 million, from $7.2 million in the first quarter of 2007. The significant increase in revenues was due to expanded production of the China Pharma's product portfolio supported by enhanced marketing efforts. The Company believes that this extraordinary growth should provide investors with confidence in China Pharma's ability to execute on their strategic marketing plan going forward. Therefore, the Company is reiterating that its 2008 full- year revenue growth is expected to exceed 40%.

Gross profit grew 76% to $5.8 million from $3.3 million in the first quarter of 2007. Gross margins were 49.6% compared to 45.6% recorded during the first quarter of 2008 and 2007 respectively. The growth of gross profit and the improved margins were primarily due to the substantial increase in revenues and the decrease in overall production expenses in the first quarter of 2008.

Operating expenses for the three months ended March 31, 2
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. DuPont Partnering with China to Increase Farm Productivity
3. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
4. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
9. China Bio Energy Reports Fiscal 2007 Financial Results
10. Transgenomic Opens Pharmacogenomics Laboratory in China
11. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... NEW YORK & PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI ), a leading ... announced today that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. ... Israel,s Office of the Chief ... has been in receipt of grant support from the ...
(Date:12/13/2014)... CanDiag, Inc., a University of North Carolina at ... to OncoTab, Inc. , “The new name is ... said CEO and Chief Science Officer, Dr. Pinku Mukherjee, ... diagnostics to include imaging and therapies, and our new ... in 2011 by Dr. Mukherjee, an Irwin Belk Endowed ...
(Date:12/13/2014)... 2014 The “Global Synthetic Biology ... drivers, threats, opportunities, and challenges. , The global ... players, namely, Thermo Fisher Scientific, Inc. (U.S.), DuPont ... jointly accounted for approximately ~65% of the total ... Copy for This Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html ...
(Date:12/13/2014)... , Dec. 12, 2014  Vaccinex Inc., ... discovery and development of therapeutic monoclonal antibodies ... announced publication of a manuscript entitled "SEMA4D ... remyelination in neurodegenerative disease" in the January ... Disease*.  The publication highlights an important role ...
Breaking Biology Technology:BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2
... for Consistent,Electronic Health Record for All Citizens Using ... GREAT RIVER, N.Y., Oct. 16 Netsmart ... services for health and,human services organizations, today announced ... services contract by the City and County of ...
... on InterMune Phase 3 CAPACITY Program - ... patient retention rate in CAPACITY -, BRISBANE, Calif., Oct. ... on October 16, 2008, the Japanese,Ministry of Health, Labor and ... & Co. Ltd. to market pirfenidone,for the treatment of patients ...
... a leading center for medical excellence; collaboration will focus ... biomaterials and ... grant from the John S.,and James L. Knight Foundation, five leading ... in,Akron -- a unique collaboration that will expand upon the region,s ...
Cached Biology Technology:Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System 2Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System 3InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 2InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 3InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF 4BioInnovation Institute in Akron Launched 2BioInnovation Institute in Akron Launched 3BioInnovation Institute in Akron Launched 4
(Date:11/21/2014)... MOUNTAIN VIEW, Calif. , Nov. 20, 2014 /PRNewswire/ ... for higher driver efficiency are piloting the North American ... the number of accidents growing, gesture recognition systems that ... will make a mark in the industry. ... of the Automotive Gesture Recognition Market in ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
(Date:11/10/2014)... U.S. store shelves in early 2010, and people have ... packets can be tossed into a washing machine without ... The convenience, though, has come with risks for young ... Children,s Hospital found that from 2012 through 2013, U.S. ... than 6 years of age swallowing, inhaling, or otherwise ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Study finds laundry detergent pods, serious poisoning risk for children 2
... 2008) Transfusion science, a discipline ... associated with blood transfusion and tissue transplantation, has made ... of an informative book in this field, Transfusion ... The first edition of Transfusion Science ...
... schizophrenia, major depression and cancer are not caused ... A novel computational biology method developed by a ... http://www.njit.edu/news/2008/2008-367.php , associate professor in NJIT,s department of ... to uncover the critical genes responsible for disease ...
... California team that developed a successful insect pest ... pesticide reduction, will be honored at the Entomological ... in Reno. The seven-member Almond Pest Management ... the Entomological Foundation,s "2008 Award for Excellence in ...
Cached Biology News:New book includes advances in the science and practice of transfusion and transplantation 2NJIT professor finds engineering technique to identify disease-causing genes 2Almond pest management team to receive major award at ESA meeting 2
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
...
DONOR BOVINE SERUM AND PLASMA...
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: